Clinical trial
The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy.
NCT05160493 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy.
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 20, 2021
- Completion date
- June 20, 2024
- Enrollment
- 246 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic postsurgical pain